Transform Pharmaceuticals
Lexington, Massachusetts, United States
About Transform Pharmaceuticals
Transform Pharmaceuticals was a pharmaceuticals company specializing in the discovery of improved formulations and novel crystalline forms of drug molecules. Transform’s product portfolio included Topiramate, an anti-epileptic drug. The company was acquired by Johnson & Johnson in 2005. The company was founded in 1998.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Funding stage: M&A
- Last round: Series Unknown (Jan 2002)
- Website: transformpharma.com
- Phone: (781)674-8000
Industries & Categories
Biotechnology, Health Care
Canonical: https://fsome.com/organization/transform-pharmaceuticals-2557996 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.